ESR1 and breast neoplasm: In analyses on breast tumor subtypes defined by individual markers, BMI was significantly positively associated with risk of ER+, PR+, HER2-, Ki67low, Bcl-2+ and p53- tumors among postmenopausal non-users of HT (Additional file 2: Table S6).